Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/21/suppl_7/vii196/485155/mdq376.pdf
Reference13 articles.
1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Non-small Cell Lung Cancer Collaborative Group;Br Med J,1995
2. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA NSCLC;Keller;N Engl J Med,2000
3. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer;Scagliotti;J Natl Cancer Inst,2003
4. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;International Adjuvant Lung Cancer Trial Collaborative Group;N Engl J Med,2004
5. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy;Olaussen;N Engl J Med,2006
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Baicalin induces cell death of non-small cell lung cancer cells via MCOLN3-mediated lysosomal dysfunction and autophagy blockage;Phytomedicine;2024-10
2. Comprehensive Analysis of Surgical Strategies and Prognosis for Non- Small Cell Lung Cancer with Pleural Metastasis Detected Intraoperatively;2024-08-16
3. Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non‐small cell lung cancer;International Journal of Cancer;2024-06-20
4. Biochanin A – A G6PD inhibitor: In silico and in vitro studies in non-small cell lung cancer cells (A549);Toxicology in Vitro;2024-04
5. Osimertinib in the treatment of resected EGFR-mutated non-small cell lung cancer: a cost-effectiveness analysis in the United States;Frontiers in Pharmacology;2024-03-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3